Similar articles for PMID: 34750238

Year	Number of Results
2011	2
2012	10
2013	7
2014	6
2015	19
2016	8
2017	8
2018	11
2019	10
2020	8
2021	7
2022	11
2023	5
2024	2

1

Whole Skeletal Mean SUV Measured on ¹⁸F-NaF PET/CT Studies as a Prognostic Indicator in Patients with Bone Metastatic Breast Cancer.

Gomes Marin JF, Duarte PS, Ordones MB, Sado HN, Sapienza MT, Buchpiguel CA. Gomes Marin JF, et al. J Nucl Med Technol. 2021 Nov 8:jnmt.121.262907. doi: 10.2967/jnmt.121.262907. Online ahead of print. J Nucl Med Technol. 2021. PMID: 34750238

2

Comparison of standardized uptake values between ^99mTc-HDP SPECT/CT and ¹⁸F-NaF PET/CT in bone metastases of breast and prostate cancer.

Arvola S, Jambor I, Kuisma A, Kemppainen J, Kajander S, Seppänen M, Noponen T. Arvola S, et al. EJNMMI Res. 2019 Jan 24;9(1):6. doi: 10.1186/s13550-019-0475-z. EJNMMI Res. 2019. PMID: 30680469 Free PMC article.

3

18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.

Piccardo A, Puntoni M, Morbelli S, Massollo M, Bongioanni F, Paparo F, Altrinetti V, Gonella R, Gennari A, Iacozzi M, Sambuceti G, DeCensi A. Piccardo A, et al. Nuklearmedizin. 2015;54(4):163-72. doi: 10.3413/Nukmed-0727-15-02. Epub 2015 Jul 13. Nuklearmedizin. 2015. PMID: 26165806

4

Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancer.

Ueda CE, Duarte PS, de Castroneves LA, Flávio J, Marin G, Sado HN, Sapienza MT, Hoff AO, Buchpiguel CA. Ueda CE, et al. Nucl Med Commun. 2020 May;41(5):469-476. doi: 10.1097/MNM.0000000000001175. Nucl Med Commun. 2020. PMID: 32187160

5

Prospective Study of Serial ¹⁸F-FDG PET and ¹⁸F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer.

Peterson LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, Jenkins I, Lee JH, Shields A, Montgomery S, Linden HM, Gralow J, Gadi VK, Muzi M, Kinahan P, Mankoff D, Specht JM. Peterson LM, et al. J Nucl Med. 2018 Dec;59(12):1823-1830. doi: 10.2967/jnumed.118.211102. Epub 2018 May 10. J Nucl Med. 2018. PMID: 29748233 Free PMC article.

6

Comparison of the Variability of SUV Normalized by Skeletal Volume with the Variability of SUV Normalized by Body Weight in ¹⁸F-Fluoride PET/CT.

Gomes Marin JF, Duarte PS, Willegaignon de Amorim de Carvalho J, Sado HN, Sapienza MT, Buchpiguel CA. Gomes Marin JF, et al. J Nucl Med Technol. 2019 Mar;47(1):60-63. doi: 10.2967/jnmt.118.215111. Epub 2018 Aug 23. J Nucl Med Technol. 2019. PMID: 30139886 Free article.

7

Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer.

Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Pinski JK, Quinn DI. Jadvar H, et al. J Nucl Med. 2013 Aug;54(8):1195-201. doi: 10.2967/jnumed.112.114116. Epub 2013 Jun 19. J Nucl Med. 2013. PMID: 23785174 Free PMC article. Clinical Trial.

8

A Retrospective Comparative Study of Sodium Fluoride Na¹⁸F-PET/CT and ⁶⁸Ga-PSMA-11 PET/CT in the Bone Metastases of Prostate Cancer Using a Volumetric 3-D Radiomic Analysis.

Kairemo K, Kangasmäki A, Kappadath SC, Joensuu T, Macapinlac HA. Kairemo K, et al. Life (Basel). 2022 Nov 25;12(12):1977. doi: 10.3390/life12121977. Life (Basel). 2022. PMID: 36556342 Free PMC article.

9

Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.

Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A. Minamimoto R, et al. J Nucl Med. 2015 Dec;56(12):1862-8. doi: 10.2967/jnumed.115.162610. Epub 2015 Sep 24. J Nucl Med. 2015. PMID: 26405167 Free article.

10

A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis.

Kairemo K, Kappadath SC, Joensuu T, Macapinlac HA. Kairemo K, et al. Diagnostics (Basel). 2020 Dec 24;11(1):17. doi: 10.3390/diagnostics11010017. Diagnostics (Basel). 2020. PMID: 33374148 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year